R Liesner Selected Research

Factor X Deficiency

11/2018	Prophylactic treatment of bleeding episodes in children <12 years with moderate to severe hereditary factor X deficiency (FXD): Efficacy and safety of a high-purity plasma-derived factor X (pdFX) concentrate.
1/2009	Prophylaxis with prothrombin complex concentrate in four children with severe congenital factor X deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R Liesner Research Topics

Disease

13	Hemorrhage 11/2018 - 01/2000
12	Hemophilia A (Haemophilia) 05/2018 - 06/2006
4	Hemophilia B (Haemophilia B) 11/2018 - 05/2010
2	Body Weight (Weight, Body) 11/2018 - 07/2018
2	Factor X Deficiency 11/2018 - 01/2009
2	Hypersensitivity (Allergy) 01/2014 - 08/2000
2	Thrombotic Thrombocytopenic Purpura 09/2012 - 12/2000
2	Protein C Deficiency 04/2005 - 09/2004
2	Infections 09/2004 - 08/2000
2	Ischemic Stroke 01/2004 - 04/2001
2	Stroke (Strokes) 01/2004 - 04/2001
1	Pain (Aches) 09/2017
1	Musculoskeletal Diseases (Musculoskeletal Disease) 06/2015
1	Hemarthrosis 06/2015
1	von Willebrand Diseases (von Willebrand's Disease) 01/2015
1	Disease Progression 07/2013
1	Thrombasthenia (Glanzmann Thrombasthenia) 03/2008
1	Fetal Distress 07/2006
1	Dehydration (Water Stress) 07/2006
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 07/2006
1	Protein S Deficiency (Deficiency, Protein S) 04/2005
1	Activated Protein C Resistance (APC Resistance) 04/2005
1	Thromboembolism 01/2004
1	Thrombosis (Thrombus) 01/2004
1	Menorrhagia 04/2002
1	Autosomal Recessive 3 Severe Congenital Neutropenia 11/2001
1	Thrombocytopenia (Thrombopenia) 12/2000
1	Fever (Fevers) 12/2000
1	Hemolytic Anemia 12/2000
1	Hermanski-Pudlak Syndrome (Hermansky-Pudlak Syndrome) 11/2000

Drug/Important Bio-Agent (IBA)

6	Factor VIII (Coagulation Factor VIII)IBA 03/2017 - 06/2006
3	Factor IX (Coagulation Factor IX)FDA LinkGeneric 11/2018 - 05/2010
3	Blood Coagulation Factors (Coagulation Factor)IBA 01/2015 - 07/2014
2	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 03/2017 - 03/2016
2	human F8 protein FDA Link 03/2016 - 03/2015
2	factor VIII-Fc fusion proteinIBA 01/2016 - 06/2015
2	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 01/2015 - 09/2007
2	thiamine triphosphorate (TTP)IBA 09/2012 - 12/2000
2	Prothrombin (Factor II)IBA 01/2009 - 04/2005
2	Protein CIBA 04/2005 - 09/2004
2	HomocysteineIBA 04/2005 - 04/2001
2	Retinaldehyde (Retinal)IBA 04/2002 - 11/2000
1	Factor X (Stuart Factor)IBA 11/2018
1	emicizumabIBA 05/2018
1	A-factor (Streptomyces)IBA 05/2018
1	Pharmaceutical PreparationsIBA 09/2017
1	BAX 855IBA 03/2017
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 03/2017
1	N 30IBA 03/2016
1	recombinant factor VIII SQIBA 03/2015
1	B-domain-deleted factor VIIIIBA 03/2015
1	von Willebrand FactorIBA 01/2015
1	3'-(1-butylphosphoryl)adenosineIBA 11/2014
1	EpitopesIBA 01/2014
1	AntibodiesIBA 03/2011
1	Rituximab (Mabthera)FDA Link 05/2009
1	factor V LeidenIBA 07/2006
1	anti-inhibitor coagulant complexIBA 06/2006
1	AntithrombinsIBA 04/2005
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2004
1	Immunoglobulin G (IgG)IBA 01/2004
1	Immunoglobulins (Immunoglobulin)IBA 01/2004
1	Anticardiolipin AntibodiesIBA 01/2004
1	Leukocyte Elastase (Neutrophil Elastase)IBA 11/2001
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 04/2001
1	ADAMTS13 ProteinIBA 12/2000
1	Factor V (Coagulation Factor V)IBA 01/2000

Therapy/Procedure

5	Therapeutics 07/2018 - 05/2010
2	Operative Surgical Procedures 11/2018 - 07/2018
2	Catheters 07/2006 - 08/2000
1	Erythrocyte Transfusion 07/2018
1	Intravenous Infusions 06/2015
1	Stem Cell Transplantation 03/2008
1	Central Venous Catheters 09/2004
1	Subcutaneous Infusions 09/2004